Market Overview:
The global bioprosthetic valve market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of heart diseases, technological advancements in the field of bioprosthetic valves, and rising demand for minimally invasive surgeries. Based on type, the global bioprosthetic valve market is segmented into tissue aortic valves and tissue mitral valves. The tissue aortic valve segment is expected to grow at a CAGR of 8% from 2018 to 2030, owing to its advantages over mechanical prosthetic valves such as low thrombogenicity and hemolysis rates. Based on application, the global bioprosthetic valve market is segmented into hospitals and ambulatory surgery centres (ASCs). The hospitals segment accounted for majority share of the global bioprosthetic valve market in 2017 and is projected to grow at a CAGR of 7% from 2018to 2030.
Product Definition:
A bioprosthetic valve is a prosthetic heart valve that is made from animal or human tissue. Bioprosthetic valves are used to replace defective heart valves in patients who require surgery.
Tissue Aortic Valve:
The aortic valve is the largest and one of the muscular entrances to the heart. It's job is to control blood flow from entering into the body and also helps in preventing blood loss from occurring. If this valve gets damaged, it leads to various complications such as high blood pressure, chest pain, or stroke among others.
Tissue Mitral Valve:
The mitral valve is a muscular barrier that separates the blood flow from the heart muscle. It is located in the center of the lower part of your brain, just above where your collarbone meets your neck. The valve’s job is to prevent blood from backing up and entering your brain when you take a breath, and instead send it out with each heartbeat.
Application Insights:
Based on the application, the market is segmented into hospitals and ambulatory surgery centers. The hospitals segment dominated the overall industry in terms of revenue in 2017 owing to increasing prevalence of chronic diseases, such as heart valve disease, which requires surgical valve replacement. Moreover, a rise in number of surgeries for bioprosthetic valves is also expected to contribute towards growth. According to data published by ELSOFT Corporation, over 617 thousand cardiovascular procedures were performed globally in 2015 and this number is projected to reach 748 thousand by 2030. Such factors are anticipated to drive demand for bioprosthetic valves from hospital settings during the forecast period.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in the prevalence of cardiovascular diseases, increasing geriatric population, and availability of advanced technologies. Moreover, high adoption rate of bioprosthetics is also expected to drive growth over the forecast period. Asia Pacific region is anticipated to witness lucrative growth during the forecast period due to rising healthcare expenditure by governments and private sectors as well as improving healthcare infrastructure. In addition, growing awareness about heart diseases & replacement surgeries among patients from developing countries such as India & China will propel demand further over the next eight years.
Moreover, supportive government policies for R&D activities related to biotechnology products are projected favorably impact industry expansion during this period.
Growth Factors:
- Increasing prevalence of heart diseases and valve related disorders
- Growing geriatric population susceptible to heart diseases
- Rising demand for minimally invasive surgeries
- Technological advancements in bioprosthetic valves
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Bioprosthetic Valve Market Research Report
By Type
Tissue Aortic Valve, Tissue Mitral Valve
By Application
Hospitals, Ambulatory Surgery Centres
By Companies
Abbott, Boston Scientific Corporation, CryoLife, Edwards Lifesciences Corporation, Medtronic Plc, LivaNova Plc, Claret Medical, Meril Life Sciences, Neovasc Inc, Abbott, Sorin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
183
Number of Tables & Figures
129
Customization Available
Yes, the report can be customized as per your need.
Global Bioprosthetic Valve Market Report Segments:
The global Bioprosthetic Valve market is segmented on the basis of:
Types
Tissue Aortic Valve, Tissue Mitral Valve
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgery Centres
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Boston Scientific Corporation
- CryoLife
- Edwards Lifesciences Corporation
- Medtronic Plc
- LivaNova Plc
- Claret Medical
- Meril Life Sciences
- Neovasc Inc
- Abbott
- Sorin
Highlights of The Bioprosthetic Valve Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tissue Aortic Valve
- Tissue Mitral Valve
- By Application:
- Hospitals
- Ambulatory Surgery Centres
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bioprosthetic Valve Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A bioprosthetic valve is a medical device that replaces a natural valve in the heart.
Some of the key players operating in the bioprosthetic valve market are Abbott, Boston Scientific Corporation, CryoLife, Edwards Lifesciences Corporation, Medtronic Plc, LivaNova Plc, Claret Medical, Meril Life Sciences, Neovasc Inc, Abbott, Sorin.
The bioprosthetic valve market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bioprosthetic Valve Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bioprosthetic Valve Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bioprosthetic Valve Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bioprosthetic Valve Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bioprosthetic Valve Market Size & Forecast, 2020-2028
4.5.1 Bioprosthetic Valve Market Size and Y-o-Y Growth
4.5.2 Bioprosthetic Valve Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Tissue Aortic Valve
5.2.2 Tissue Mitral Valve
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgery Centres
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bioprosthetic Valve Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bioprosthetic Valve Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Tissue Aortic Valve
9.6.2 Tissue Mitral Valve
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgery Centres
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Tissue Aortic Valve
10.6.2 Tissue Mitral Valve
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgery Centres
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Tissue Aortic Valve
11.6.2 Tissue Mitral Valve
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgery Centres
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Tissue Aortic Valve
12.6.2 Tissue Mitral Valve
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgery Centres
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Tissue Aortic Valve
13.6.2 Tissue Mitral Valve
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgery Centres
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bioprosthetic Valve Market: Competitive Dashboard
14.2 Global Bioprosthetic Valve Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Boston Scientific Corporation
14.3.3 CryoLife
14.3.4 Edwards Lifesciences Corporation
14.3.5 Medtronic Plc
14.3.6 LivaNova Plc
14.3.7 Claret Medical
14.3.8 Meril Life Sciences
14.3.9 Neovasc Inc
14.3.10 Abbott
14.3.11 Sorin
